Copied to clipboard!
Intron Retention Regulates STAT2 Function and Predicts Response to Immunotherapy in Lung Adenocarcinoma
We utilized long-read sequencing of RNA extracted from bulk human lung adenocarcinoma (LUAD) tumors to identify novel isoforms that play a role in tumor biology and to identify new targets for therapeutic intervention. Using these data, we identified previously undescribed intron retention events in the inflammatory signaling molecule STAT2 that regulate STAT2 function in LUAD tumors and predict responses to checkpoint blockade immunotherapy in LUAD patients. These results highlight the value of STAT2 retained introns as therapeutic targets and potential biomarkers for treatment of this disease.
- Type: Tumor vs. Matched-Normal
- Archive: The database of Genotypes and Phenotypes (dbGaP)
